These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19712990)

  • 21. Measuring concerns for severity: re-examination of a health scale with purported equal interval properties.
    Nord E
    Health Policy; 2012 May; 105(2-3):312-6. PubMed ID: 22444761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equity Weights for Priority Setting in Healthcare: Severity, Age, or Both?
    Reckers-Droog V; van Exel J; Brouwer W
    Value Health; 2019 Dec; 22(12):1441-1449. PubMed ID: 31806201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discrete choice experiments to measure consumer preferences for health and healthcare.
    Viney R; Lancsar E; Louviere J
    Expert Rev Pharmacoecon Outcomes Res; 2002 Aug; 2(4):319-26. PubMed ID: 19807438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with multiple needs for healthcare and priority to the worse off.
    Gustavsson E
    Bioethics; 2019 Feb; 33(2):261-266. PubMed ID: 30480809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics.
    Morrell L; Wordsworth S; Rees S; Barker R
    Pharmacoeconomics; 2017 Aug; 35(8):793-804. PubMed ID: 28455834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What is meant by "severity of illness"?].
    Olsen JA
    Tidsskr Nor Laegeforen; 2013 Jan; 133(1):64-7. PubMed ID: 23306998
    [No Abstract]   [Full Text] [Related]  

  • 27. Health status index models for use in resource allocation decisions. A critical review in the light of observed preferences for social choice.
    Nord E
    Int J Technol Assess Health Care; 1996; 12(1):31-44. PubMed ID: 8690560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A person trade-off study to estimate age-related weights for health gains in economic evaluation.
    Petrou S; Kandala NB; Robinson A; Baker R
    Pharmacoeconomics; 2013 Oct; 31(10):893-907. PubMed ID: 23990389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How stable are people's preferences for giving priority to severely ill patients?
    Ubel PA
    Soc Sci Med; 1999 Oct; 49(7):895-903. PubMed ID: 10468394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whose preferences count?
    Dolan P
    Med Decis Making; 1999; 19(4):482-6. PubMed ID: 10520686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rare diseases in healthcare priority setting: should rarity matter?
    Albertsen A
    J Med Ethics; 2022 Sep; 48(9):624-628. PubMed ID: 34103369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Centring race, deprivation, and disease severity in healthcare priority setting.
    Shahvisi A
    J Med Ethics; 2022 Feb; 48(2):77-78. PubMed ID: 35064068
    [No Abstract]   [Full Text] [Related]  

  • 33. The Severity of Illness Index and laboratory testing.
    Willan AR; MacKenzie TA
    Can J Public Health; 1988; 79(6):435-9. PubMed ID: 3148364
    [No Abstract]   [Full Text] [Related]  

  • 34. Allocating healthcare resources-seriously ill people should have priority.
    BMJ; 2018 May; 361():k2291. PubMed ID: 29794064
    [No Abstract]   [Full Text] [Related]  

  • 35. Revealing and acknowledging value judgments in health technology assessment.
    Hofmann B; Cleemput I; Bond K; Krones T; Droste S; Sacchini D; Oortwijn W
    Int J Technol Assess Health Care; 2014 Dec; 30(6):579-86. PubMed ID: 25816823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Making use of equity sensitive QALYs: a case study on identifying the worse off across diseases.
    Lindemark F; Norheim OF; Johansson KA
    Cost Eff Resour Alloc; 2014; 12():16. PubMed ID: 25089121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "It's hard to say anything definitive about what severity really is": lay conceptualisations of severity in a healthcare context.
    Stenmarck MS; Whitehurst DG; Lurås H; Rugkåsa J
    BMC Health Serv Res; 2024 Apr; 24(1):490. PubMed ID: 38641590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experiment.
    Yin Y; Peng Q; Ma L; Dong Y; Sun Y; Xu S; Ding N; Liu X; Zhao M; Tang Y; Mei Z; Shao H; Yan D; Tang W
    Qual Life Res; 2024 Mar; 33(3):753-765. PubMed ID: 38079024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severity as a moral qualifier of malady.
    Solberg CT; Barra M; Sandman L; Hoffmann B
    BMC Med Ethics; 2023 Mar; 24(1):25. PubMed ID: 37004054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perceived COVID-19 susceptibility and preventive behaviors: moderating effects of social support in Italy and South Korea.
    An S; Schulz PJ; Kang H
    BMC Public Health; 2023 Jan; 23(1):13. PubMed ID: 36597060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.